Safety in TRIUMPH-1 The safety profile was consistent with incretin-class therapies: Most common AEs (12 mg dose): - Nausea: 42.4% - Diarrhea: 32.0% - Constipation: 26.1% - Vomiting: 25.3% Dysesthesia (a sensory disturbance tingling, numbness) and urinary tract infections were reported in approximately 10% of patients on the highest doses, but were generally mild to moderate and mostly resolved during treatment
Manfredi G, Beal MF (2000) The role of mitochondria in the pathogenesis of neurodegenerative diseases
A dual GLP-1/glucagon agonist in Phase 3, with about 19% weight loss reported in Phase 2
It is released into the blood very early after liver injury often before ALT rises making it a promising early-warning signal
Younger consumers (20s to 30s) practicing preventive anti-aging: A copper peptide sunscreen is an accessible, daily entry point into the skin longevity movement
Thank you for being a Citizen Scientist When you order your Glutathione test which you can buy as a single test here OR as part of the DRIfT 5 in 1 test bundle here you can become a part of our team of Citizen Scientists